NCT00498303View on ClinicalTrials.gov

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2007

Conditions
Seasonal InfluenzaVaccine
Interventions
BIOLOGICAL

trivalent split influenza vaccine

Trial Locations (1)

35745

Werksarztzentrum Herborn, Herborn

Sponsors

Lead Sponsor

Novartis

Collaborators (1)

Novartis Vaccines
All Listed Sponsors
collaborator

Novartis Vaccines

INDUSTRY

lead

Novartis

INDUSTRY